Cargando…

Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US

Detalles Bibliográficos
Autores principales:	Martinez, Carlos, Watson, Douglas J., Shebl, Amgad, Wallenhorst, Christopher, Hubsch, Alphonse, Simon, Toby L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725686/ https://www.ncbi.nlm.nih.gov/pubmed/28983941 http://dx.doi.org/10.1002/ajh.24931

Ejemplares similares

Anti‐A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital‐based cohort study
por: Wallenhorst, Christopher, et al.
Publicado: (2020)

Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports
por: Shebl, Amgad, et al.
Publicado: (2020)

Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations
por: Cuesta, Hillary, et al.
Publicado: (2022)

Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
por: KC, Ojbindra, et al.
Publicado: (2023)

Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports
por: Sedlin, E., et al.
Publicado: (2023)

Thromboembolism Early After Glucocorticoid Administration in Patients with Autoimmune Hemolytic Anemia
por: Shiroshita, Kohei, et al.
Publicado: (2023)

Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia
por: Koumaki, Dimitra, et al.
Publicado: (2021)

Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases
por: Berard, Roberta, et al.
Publicado: (2012)

Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
por: Lee, Boram, et al.
Publicado: (2020)

Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin
por: Abghari, Pamella F., et al.
Publicado: (2017)

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection
por: Ben-Nathan, David, et al.
Publicado: (2009)

PRACTICAL ISSUES FOR CLINICIANS USING HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
por: Khan, S, et al.
Publicado: (2011)

Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants with Hemolytic Disease
por: Mohan, Daniel R., et al.
Publicado: (2023)

Ceftriaxone-induced immune hemolytic anemia in a case with large vestibular aqueduct syndrome after cochlear implant
por: Wang, Yu, et al.
Publicado: (2019)

Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses
por: Yamamoto, Haruko, et al.
Publicado: (2022)

The use of high‐dose immunoglobulin M‐enriched human immunoglobulin in dogs with immune‐mediated hemolytic anemia
por: Bestwick, Jason P., et al.
Publicado: (2021)

Severe congenital hemolytic anemia caused by a novel compound heterozygous PKLR gene mutation in a Chinese boy
por: Liu, Peng-Peng, et al.
Publicado: (2019)

The importance of the immunohematologic evaluation for presumed autoimmune hemolytic anemia in the COVID-19 era
por: Jacobs, Jeremy W., et al.
Publicado: (2023)

A 2-month-old boy with hemolytic anemia and reticulocytopenia following intravenous immunoglobulin therapy for Kawasaki disease: a case report and literature review
por: Kim, Na Yeon, et al.
Publicado: (2016)

Clinical Experience With an L-Proline–Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability
por: Dorsey, Morna J., et al.
Publicado: (2014)

Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion
por: Okulu, Emel, et al.
Publicado: (2022)

Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment
por: Gerber, Simon, et al.
Publicado: (2016)

Remission of Subacute Psychosis in a COVID-19 Patient With an Antineuronal Autoantibody After Treatment With Intravenous Immunoglobulin
por: McAlpine, Lindsay S., et al.
Publicado: (2021)

Anti A/B Antibody Titer Rebound: Are we Making it Worse? Be Aware of Your Intravenous Immunoglobulin
por: Kher, A., et al.
Publicado: (2018)

Identification of hemolytic activity and hemolytic genes of Methicillin-resistant Staphylococcus aureus isolated from Chinese children
por: Wang, Li-Juan, et al.
Publicado: (2020)

Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia
por: Wang, Jing-Zhi, et al.
Publicado: (2021)

Rapidly Progressing Generalized Morphea with High Lyme Disease Titer
por: Choi, Mi Soo, et al.
Publicado: (2020)

Pulmonary hypertension in hemolytic anemias
por: Wahl, Shannon, et al.
Publicado: (2010)

About Microangiopathic Hemolytic Anemia
por: Özsoylu, Şinasi
Publicado: (2015)

Thymoma with Autoimmune Hemolytic Anemia
por: Suzuki, Kensuke, et al.
Publicado: (2014)

Ibuprofen-Induced Hemolytic Anemia
por: Barbaryan, Aram, et al.
Publicado: (2013)

Metformin-Induced Hemolytic Anemia
por: Kirkiz, Serap, et al.
Publicado: (2014)

Hemolytic Anemias: Autoimmune and Beyond
por: Krishnadasan, Ravi
Publicado: (2021)

Hemolytic anemia in COVID-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Vancomycin-Induced Hemolytic Anemia
por: Siddiqui, Fakeha, et al.
Publicado: (2023)

Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency
por: Rojavin, Mikhail A., et al.
Publicado: (2016)

Lichen Planus in Silicosis Patient with Unusually High Antinuclear Antibody Titer
por: Gupta, Isha, et al.
Publicado: (2017)

Hemolytic Anemia in Inflammatory Bowel Disease: Our “Gut” Tells Us to Blame the Drug
por: Berger, Matthew, et al.
Publicado: (2021)

Hemolytic uremic syndrome caused by Escherichia fergusonii infection
por: Baek, Seung Don, et al.
Publicado: (2019)

In reply: the evaluation of IgG titers' stability from blood samples is necessary
por: Ouh, Yung-Taek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pfefsp55dt7nbgaecacvta786l